Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Kabos

Concepts (401)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
52
2025
2142
5.830
 Why?
Receptors, Estrogen
21
2025
426
3.090
 Why?
Receptor, ErbB-2
14
2024
326
2.000
 Why?
Receptors, Progesterone
11
2020
343
1.250
 Why?
Brain Neoplasms
14
2023
1171
1.000
 Why?
Keratin-5
6
2022
50
0.850
 Why?
Estrogens
7
2023
347
0.820
 Why?
Triple Negative Breast Neoplasms
6
2023
197
0.810
 Why?
Breast Neoplasms, Male
3
2018
29
0.790
 Why?
Biomarkers, Tumor
7
2022
1181
0.780
 Why?
Stem Cells
8
2006
577
0.770
 Why?
Antineoplastic Agents, Hormonal
7
2025
158
0.720
 Why?
Tetrahydronaphthalenes
1
2021
30
0.710
 Why?
Estrogen Receptor alpha
4
2024
133
0.700
 Why?
Drug Resistance, Neoplasm
5
2025
759
0.700
 Why?
Neoplasm Metastasis
4
2020
610
0.690
 Why?
Immunoprecipitation
4
2020
157
0.680
 Why?
Neoplastic Cells, Circulating
1
2020
71
0.660
 Why?
Benzodiazepines
1
2021
136
0.660
 Why?
Radiosurgery
3
2023
321
0.650
 Why?
Brain Edema
2
2023
60
0.650
 Why?
Neurons
8
2004
1511
0.640
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
54
0.610
 Why?
Epithelial-Mesenchymal Transition
1
2020
202
0.600
 Why?
Leukocytes, Mononuclear
2
2020
545
0.590
 Why?
Gene Expression Regulation, Neoplastic
11
2025
1356
0.570
 Why?
Gene Expression Profiling
7
2020
1706
0.570
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
5
0.550
 Why?
Polyadenylation
1
2017
40
0.540
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2024
1565
0.540
 Why?
High-Throughput Nucleotide Sequencing
4
2019
487
0.540
 Why?
Neoplastic Stem Cells
7
2020
380
0.540
 Why?
Female
54
2025
68776
0.540
 Why?
Organoplatinum Compounds
1
2016
41
0.540
 Why?
Carcinogenesis
2
2020
213
0.530
 Why?
Cancer-Associated Fibroblasts
1
2016
13
0.530
 Why?
Fluorouracil
1
2016
199
0.500
 Why?
Artifacts
1
2016
126
0.490
 Why?
CD146 Antigen
3
2021
41
0.480
 Why?
Mitochondrial Proteins
1
2017
248
0.480
 Why?
Thrombocytopenia
1
2016
186
0.460
 Why?
MCF-7 Cells
4
2020
116
0.460
 Why?
Maytansine
1
2014
16
0.460
 Why?
Cell Line, Tumor
15
2025
3215
0.440
 Why?
Humans
67
2025
129650
0.440
 Why?
Trastuzumab
5
2023
101
0.410
 Why?
Analgesics, Opioid
1
2021
913
0.410
 Why?
Binding Sites
1
2016
1252
0.410
 Why?
RNA-Binding Proteins
1
2016
388
0.400
 Why?
Tumor Microenvironment
4
2021
634
0.390
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
217
0.390
 Why?
Neoplasms, Hormone-Dependent
1
2012
38
0.390
 Why?
Antineoplastic Agents
4
2023
2061
0.390
 Why?
Tamoxifen
5
2025
200
0.390
 Why?
Homeodomain Proteins
5
2018
495
0.380
 Why?
MicroRNAs
5
2016
678
0.370
 Why?
Piperazines
2
2024
342
0.370
 Why?
Neoplasm Recurrence, Local
5
2021
964
0.370
 Why?
Chemotherapy, Adjuvant
5
2023
381
0.360
 Why?
Protein Kinase Inhibitors
5
2021
891
0.360
 Why?
RNA
2
2016
883
0.360
 Why?
Estradiol
3
2015
494
0.360
 Why?
Neoadjuvant Therapy
3
2021
383
0.350
 Why?
Mutation
3
2021
3717
0.350
 Why?
Antibodies, Monoclonal, Humanized
2
2021
759
0.340
 Why?
Pyridines
2
2024
478
0.340
 Why?
Liver Neoplasms
1
2015
640
0.340
 Why?
Progestins
5
2020
78
0.330
 Why?
Pyrimidines
3
2018
459
0.320
 Why?
Colorectal Neoplasms
1
2016
752
0.310
 Why?
Tumor Cells, Cultured
7
2020
940
0.310
 Why?
Prognosis
7
2021
3794
0.310
 Why?
Carcinoma, Ductal, Breast
2
2020
82
0.300
 Why?
Adenocarcinoma
1
2015
898
0.300
 Why?
Hydrocephalus
3
2023
107
0.300
 Why?
Bone Marrow Cells
2
2014
300
0.290
 Why?
Signal Transduction
5
2018
4925
0.280
 Why?
Middle Aged
16
2024
31154
0.280
 Why?
Neoplasm Staging
4
2021
1295
0.260
 Why?
Astrocytes
5
2023
201
0.260
 Why?
Helix-Loop-Helix Motifs
2
2002
12
0.260
 Why?
Necrosis
2
2019
232
0.250
 Why?
Cluster Analysis
4
2019
482
0.250
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.240
 Why?
Sequence Analysis, RNA
2
2019
429
0.240
 Why?
Fatty Acid Synthase, Type I
1
2025
11
0.240
 Why?
Neuroglia
2
2003
168
0.240
 Why?
Aged
14
2024
22103
0.230
 Why?
Neoplasm Grading
2
2017
285
0.230
 Why?
Genetic Therapy
2
2003
292
0.230
 Why?
Mice, Inbred NOD
5
2021
588
0.220
 Why?
Aromatase Inhibitors
2
2021
51
0.220
 Why?
Disease-Free Survival
4
2024
648
0.220
 Why?
Carbolines
1
2024
30
0.220
 Why?
Triazines
1
2024
38
0.220
 Why?
Adult
16
2024
35576
0.220
 Why?
Animals
27
2021
35361
0.210
 Why?
Progesterone
3
2014
245
0.210
 Why?
Morpholines
1
2024
122
0.210
 Why?
Extracellular Matrix Proteins
1
2004
144
0.210
 Why?
Glioma
5
2006
354
0.200
 Why?
Mice
19
2021
16937
0.200
 Why?
Keratin-17
1
2022
4
0.200
 Why?
Aquaporin 4
2
2023
95
0.200
 Why?
Nerve Regeneration
1
2002
62
0.200
 Why?
Stromal Cells
2
2020
107
0.200
 Why?
Triglycerides
1
2025
527
0.200
 Why?
Mice, SCID
4
2020
351
0.200
 Why?
Tumor Suppressor Proteins
2
2015
317
0.200
 Why?
Immunoconjugates
1
2023
103
0.190
 Why?
Down-Regulation
4
2015
636
0.190
 Why?
Cell-Free Nucleic Acids
1
2022
31
0.190
 Why?
Neoplasm Invasiveness
3
2020
485
0.190
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.190
 Why?
Medicare
3
2023
720
0.190
 Why?
Lipid Metabolism
1
2025
497
0.190
 Why?
Cyclins
1
2002
89
0.190
 Why?
Aged, 80 and over
4
2024
7086
0.180
 Why?
Tumor Suppressor Protein p53
2
2015
511
0.180
 Why?
Gene Regulatory Networks
2
2014
284
0.180
 Why?
Insulin Receptor Substrate Proteins
1
2020
59
0.180
 Why?
gamma-Aminobutyric Acid
1
2002
169
0.180
 Why?
Cell Adhesion Molecules
1
2021
173
0.170
 Why?
RNA, Messenger
3
2019
2708
0.170
 Why?
Cancer Care Facilities
1
2020
32
0.170
 Why?
Meningeal Carcinomatosis
1
2020
8
0.170
 Why?
Hyaluronan Receptors
4
2014
96
0.170
 Why?
SEER Program
1
2021
206
0.170
 Why?
Carcinoma, Lobular
1
2020
48
0.170
 Why?
Antineoplastic Agents, Immunological
2
2019
181
0.170
 Why?
Transcriptome
2
2019
887
0.160
 Why?
Cell Proliferation
6
2025
2391
0.160
 Why?
Aminopyridines
1
2020
97
0.160
 Why?
Gene Library
2
2019
116
0.160
 Why?
Collagen
2
2020
434
0.160
 Why?
Repressor Proteins
1
2002
406
0.160
 Why?
Retrospective Studies
5
2023
14518
0.160
 Why?
Lymphatic Metastasis
2
2017
320
0.160
 Why?
Benzimidazoles
1
2020
162
0.160
 Why?
Antigens, Neoplasm
1
2021
309
0.160
 Why?
ErbB Receptors
2
2020
607
0.150
 Why?
Paclitaxel
1
2020
217
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
52
0.150
 Why?
beta Catenin
1
2020
223
0.140
 Why?
Xenograft Model Antitumor Assays
4
2017
814
0.140
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2017
81
0.140
 Why?
Heterografts
4
2020
131
0.140
 Why?
Treatment Outcome
5
2023
10230
0.140
 Why?
RNA Polymerase III
1
2017
26
0.140
 Why?
Disease Progression
4
2018
2635
0.140
 Why?
3' Untranslated Regions
1
2017
138
0.130
 Why?
Pyrroles
1
2017
202
0.130
 Why?
Neoplasms, Radiation-Induced
1
2016
71
0.130
 Why?
Genital Neoplasms, Female
1
2017
82
0.130
 Why?
Single-Cell Analysis
1
2019
277
0.130
 Why?
Receptors, Androgen
1
2017
147
0.130
 Why?
Gene Expression
2
2016
1472
0.120
 Why?
Ovary
1
2017
210
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
958
0.120
 Why?
Neoplasms, Second Primary
1
2016
106
0.120
 Why?
Combined Modality Therapy
2
2019
1206
0.120
 Why?
Ribosomal Proteins
1
2015
77
0.120
 Why?
Paracrine Communication
1
2015
61
0.120
 Why?
Proto-Oncogene Proteins c-akt
1
2017
431
0.120
 Why?
DNA Primers
1
2016
510
0.120
 Why?
Pyrazoles
1
2018
405
0.120
 Why?
Risk Reduction Behavior
1
2016
209
0.120
 Why?
Hodgkin Disease
1
2016
134
0.120
 Why?
Fibroblasts
1
2020
948
0.120
 Why?
Obesity
2
2018
2883
0.110
 Why?
Reactive Oxygen Species
1
2017
596
0.110
 Why?
Azepines
1
2015
89
0.110
 Why?
STAT5 Transcription Factor
1
2014
48
0.110
 Why?
Peptides
1
2020
925
0.110
 Why?
Clinical Decision-Making
1
2017
303
0.110
 Why?
Odds Ratio
1
2017
1023
0.110
 Why?
Receptors, Steroid
1
2014
49
0.110
 Why?
Apoptosis
4
2017
2503
0.110
 Why?
Opioid-Related Disorders
1
2021
484
0.100
 Why?
Sensitivity and Specificity
2
2016
1838
0.100
 Why?
Disease Models, Animal
4
2017
4063
0.100
 Why?
CD24 Antigen
1
2012
20
0.100
 Why?
DNA-Binding Proteins
2
2015
1443
0.100
 Why?
RNA Interference
1
2014
448
0.100
 Why?
Retinoids
1
2012
33
0.100
 Why?
Anthracyclines
2
2023
49
0.100
 Why?
Cell Differentiation
4
2004
1902
0.100
 Why?
Clinical Trials as Topic
1
2017
1004
0.100
 Why?
Comorbidity
1
2017
1547
0.100
 Why?
Taxoids
2
2023
98
0.100
 Why?
Male
8
2018
63681
0.100
 Why?
United States
4
2023
13903
0.090
 Why?
Doxorubicin
3
2022
325
0.090
 Why?
Genome, Human
1
2014
393
0.090
 Why?
Small Molecule Libraries
1
2012
86
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
169
0.090
 Why?
Drug Discovery
1
2012
131
0.090
 Why?
Tumor Burden
1
2012
286
0.090
 Why?
Mitochondria
1
2017
877
0.090
 Why?
Rats
5
2017
5500
0.090
 Why?
Logistic Models
1
2016
1988
0.090
 Why?
Basic Helix-Loop-Helix Transcription Factors
2
2002
237
0.090
 Why?
Time Factors
3
2020
6556
0.080
 Why?
Lung Neoplasms
1
2023
2344
0.080
 Why?
Dendritic Cells
2
2004
478
0.080
 Why?
Nuclear Proteins
1
2015
663
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
769
0.080
 Why?
Estrogen Antagonists
1
2010
45
0.080
 Why?
Protein Binding
1
2016
2121
0.080
 Why?
Transforming Growth Factor beta
1
2012
457
0.080
 Why?
BRCA2 Protein
1
2009
53
0.080
 Why?
Administration, Oral
2
2024
786
0.080
 Why?
Cell Culture Techniques
2
2020
345
0.080
 Why?
Pregnancy Complications, Neoplastic
1
2009
53
0.080
 Why?
Thrombophilia
1
2009
81
0.080
 Why?
Receptors, CXCR4
2
2006
83
0.080
 Why?
Quinolines
2
2021
156
0.080
 Why?
Practice Patterns, Physicians'
1
2017
1266
0.080
 Why?
Cell Movement
3
2015
945
0.070
 Why?
Cells, Cultured
3
2006
4083
0.070
 Why?
Brain
2
2023
2679
0.070
 Why?
Stem Cell Transplantation
3
2004
166
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2002
1198
0.070
 Why?
Genetic Predisposition to Disease
1
2016
2282
0.070
 Why?
Proteoglycans
2
2006
110
0.070
 Why?
Rats, Sprague-Dawley
2
2002
2406
0.070
 Why?
Radiotherapy, Adjuvant
2
2018
210
0.070
 Why?
Risk Factors
2
2020
9765
0.070
 Why?
Drug Delivery Systems
1
2010
336
0.070
 Why?
Immunohistochemistry
2
2017
1698
0.070
 Why?
Aurora Kinase A
2
2018
55
0.070
 Why?
Severity of Illness Index
1
2014
2742
0.060
 Why?
Biopsy
2
2020
1097
0.060
 Why?
Nervous System
1
2006
67
0.060
 Why?
Rats, Inbred F344
2
2003
257
0.060
 Why?
Tomography, X-Ray Computed
1
2015
2535
0.060
 Why?
Neoplasm Transplantation
2
2016
257
0.060
 Why?
Mass Spectrometry
2
2020
716
0.060
 Why?
Infant, Premature, Diseases
1
2006
93
0.060
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.060
 Why?
Aggrecans
1
2004
14
0.060
 Why?
Isoquinolines
1
2024
41
0.060
 Why?
Lectins, C-Type
1
2004
71
0.060
 Why?
Azetidines
1
2024
40
0.060
 Why?
Cyclophosphamide
2
2018
232
0.050
 Why?
Maximum Tolerated Dose
1
2024
193
0.050
 Why?
Adipose Tissue
2
2018
592
0.050
 Why?
Cell Line
2
2014
2781
0.050
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
6
0.050
 Why?
Mastectomy, Segmental
2
2017
85
0.050
 Why?
Glioblastoma
2
2006
326
0.050
 Why?
Aromatase
1
2023
31
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
6
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
 Why?
Mice, Inbred C57BL
5
2004
5440
0.050
 Why?
Camptothecin
1
2023
109
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
55
0.050
 Why?
Edema
1
2023
124
0.050
 Why?
Pyramidal Tracts
1
2002
26
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
8
0.050
 Why?
Neurites
1
2002
47
0.050
 Why?
Sciatic Nerve
1
2002
56
0.050
 Why?
Gonadotropin-Releasing Hormone
1
2024
207
0.050
 Why?
Transcription Factor HES-1
1
2002
5
0.050
 Why?
Vimentin
1
2022
51
0.050
 Why?
Interleukin-12
1
2002
118
0.050
 Why?
Phenotype
1
2010
3076
0.050
 Why?
Frontal Lobe
1
2002
154
0.050
 Why?
Blotting, Western
1
2004
1205
0.050
 Why?
Oligonucleotides, Antisense
1
2002
113
0.050
 Why?
Fibroblast Growth Factors
1
2002
170
0.050
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
117
0.050
 Why?
Mice, Inbred BALB C
1
2004
1245
0.050
 Why?
Ependymoma
1
2003
177
0.050
 Why?
TOR Serine-Threonine Kinases
1
2024
396
0.050
 Why?
Neoplasms
1
2015
2470
0.040
 Why?
Protein-Lysine 6-Oxidase
1
2020
8
0.040
 Why?
Nucleosomes
1
2022
137
0.040
 Why?
Cerebral Cortex
1
2004
437
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Hospitals, University
1
2021
179
0.040
 Why?
Nervous System Diseases
1
2003
252
0.040
 Why?
Animals, Newborn
1
2002
835
0.040
 Why?
Membrane Glycoproteins
1
2002
474
0.040
 Why?
Adherens Junctions
1
2020
25
0.040
 Why?
Dose-Response Relationship, Drug
1
2024
2012
0.040
 Why?
Gene Knockout Techniques
1
2020
109
0.040
 Why?
Protein Interaction Mapping
1
2020
108
0.040
 Why?
Kaplan-Meier Estimate
1
2021
857
0.040
 Why?
Interferon-gamma
1
2002
770
0.040
 Why?
Mice, Nude
2
2015
683
0.040
 Why?
DNA, Complementary
1
2019
270
0.040
 Why?
beta-Galactosidase
3
2002
77
0.040
 Why?
Loss of Function Mutation
1
2018
39
0.040
 Why?
Immunotherapy
1
2003
592
0.040
 Why?
Maintenance Chemotherapy
1
2018
22
0.040
 Why?
Cadherins
1
2020
188
0.040
 Why?
Wnt Signaling Pathway
1
2020
170
0.040
 Why?
Nausea
1
2018
110
0.040
 Why?
Promoter Regions, Genetic
2
2012
1207
0.040
 Why?
Breast
1
2018
153
0.040
 Why?
Mastectomy
1
2018
131
0.030
 Why?
Phenylthiohydantoin
1
2017
44
0.030
 Why?
Diarrhea
1
2018
180
0.030
 Why?
Antigens, CD
1
2020
489
0.030
 Why?
Mammary Neoplasms, Experimental
1
2017
66
0.030
 Why?
Area Under Curve
1
2017
304
0.030
 Why?
Ovariectomy
1
2017
137
0.030
 Why?
Steroids
1
2017
158
0.030
 Why?
Benzamides
1
2017
207
0.030
 Why?
Nitriles
1
2017
172
0.030
 Why?
Fatigue
1
2018
318
0.030
 Why?
Cell Membrane
1
2020
732
0.030
 Why?
Flow Cytometry
2
2012
1156
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
182
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
64
0.030
 Why?
Chromatography, Liquid
1
2017
423
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Postmenopause
1
2017
351
0.030
 Why?
Weight Gain
1
2018
510
0.030
 Why?
Transcription Factors
1
2002
1651
0.030
 Why?
Gene Knockdown Techniques
1
2015
315
0.030
 Why?
Molecular Targeted Therapy
1
2017
390
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Jagged-1 Protein
1
2014
23
0.030
 Why?
Argonaute Proteins
1
2014
28
0.030
 Why?
Wnt-5a Protein
1
2014
21
0.030
 Why?
Software
1
2019
608
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
55
0.030
 Why?
Testosterone
1
2017
372
0.030
 Why?
Transcription, Genetic
1
2020
1418
0.030
 Why?
Cellular Microenvironment
1
2014
81
0.030
 Why?
Interleukin-6
1
2017
720
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
328
0.030
 Why?
Wnt Proteins
1
2014
127
0.030
 Why?
Guideline Adherence
1
2017
526
0.030
 Why?
Gene Expression Regulation
1
2022
2548
0.030
 Why?
Socioeconomic Factors
1
2017
1214
0.030
 Why?
Acitretin
1
2012
3
0.030
 Why?
Miconazole
1
2012
5
0.030
 Why?
Calcium-Binding Proteins
1
2014
210
0.030
 Why?
Isotretinoin
1
2012
23
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
375
0.020
 Why?
Luciferases
1
2012
148
0.020
 Why?
Genes, Reporter
1
2012
267
0.020
 Why?
Tretinoin
1
2012
130
0.020
 Why?
Biomarkers
2
2017
3973
0.020
 Why?
Magnetic Resonance Imaging
2
2019
3408
0.020
 Why?
Risk Assessment
1
2020
3240
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
530
0.020
 Why?
Green Fluorescent Proteins
1
2012
385
0.020
 Why?
Follow-Up Studies
1
2020
4897
0.020
 Why?
Diet
1
2018
1213
0.020
 Why?
Colorado
1
2020
4421
0.020
 Why?
Proto-Oncogene Proteins
1
2014
638
0.020
 Why?
Base Sequence
1
2014
2142
0.020
 Why?
HEK293 Cells
1
2012
697
0.020
 Why?
Age Factors
1
2017
3144
0.020
 Why?
Practice Guidelines as Topic
1
2017
1501
0.020
 Why?
Pregnancy Trimester, Second
1
2009
77
0.020
 Why?
Molecular Sequence Data
1
2014
2832
0.020
 Why?
Hypertension
1
2018
1242
0.020
 Why?
Pregnancy Trimester, First
1
2009
138
0.020
 Why?
Endothelial Cells
1
2014
749
0.020
 Why?
Lymph Node Excision
1
2009
164
0.020
 Why?
Transplantation, Heterologous
1
2008
192
0.020
 Why?
Membrane Proteins
1
2014
1119
0.020
 Why?
Neoplasms, Experimental
1
2008
171
0.020
 Why?
CD8-Positive T-Lymphocytes
2
2002
857
0.020
 Why?
Infant, Newborn
2
2009
5762
0.020
 Why?
CD4-Positive T-Lymphocytes
2
2002
1056
0.020
 Why?
Chemokines, CXC
1
2006
70
0.020
 Why?
Nestin
1
2006
19
0.020
 Why?
Laminin
1
2006
69
0.020
 Why?
Intermediate Filament Proteins
1
2006
57
0.020
 Why?
Chemokine CXCL12
1
2006
79
0.020
 Why?
Glial Fibrillary Acidic Protein
1
2006
92
0.020
 Why?
Lasers
1
2006
132
0.020
 Why?
Drug Combinations
1
2006
330
0.010
 Why?
Adolescent
1
2024
20393
0.010
 Why?
Culture Media, Conditioned
1
2004
110
0.010
 Why?
RNA, Small Interfering
1
2006
587
0.010
 Why?
Injections, Intralesional
1
2003
34
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
43
0.010
 Why?
3T3 Cells
1
2002
153
0.010
 Why?
Random Allocation
1
2003
346
0.010
 Why?
Nerve Tissue Proteins
1
2006
570
0.010
 Why?
Models, Neurological
1
2004
242
0.010
 Why?
Adenoviridae
1
2002
192
0.010
 Why?
Infant, Premature
1
2006
541
0.010
 Why?
Genetic Vectors
1
2002
312
0.010
 Why?
Reference Values
1
2003
793
0.010
 Why?
Oligodendroglia
1
2002
166
0.010
 Why?
Transfection
1
2002
911
0.010
 Why?
Recombinant Fusion Proteins
1
2002
643
0.010
 Why?
Survival Rate
1
2003
1877
0.010
 Why?
Case-Control Studies
1
2006
3381
0.010
 Why?
Pregnancy
1
2009
6402
0.010
 Why?
Vaccination
1
2003
1348
0.010
 Why?
Prospective Studies
1
2006
7133
0.010
 Why?
Infant
1
2006
9024
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (401) concept(s)
_
Co-Authors Expand Description
See all (69) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)